Marshall Wace LLP Decreases Stake in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)
Marshall Wace LLP lessened its stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 68.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 52,744 shares of the company’s stock after selling 112,449 shares during the quarter. Marshall Wace […]
Marshall Wace LLP lessened its stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 68.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 52,744 shares of the company’s stock after selling 112,449 shares during the quarter. Marshall Wace […]
